{"hands_on_practices": [{"introduction": "The critical first step in managing a child with an acute focal neurological deficit is distinguishing a true arterial ischemic stroke from its many mimics. This exercise challenges you to apply foundational principles of neuroimaging and electrophysiology to differentiate an ischemic stroke from Todd paralysis, a common post-seizure phenomenon. Mastering this distinction is vital for initiating appropriate, time-sensitive therapy and avoiding the risks of unnecessary treatment [@problem_id:5192248].", "problem": "A child presents with acute hemiparesis. You must choose the combination of temporal profile, electroencephalogram (EEG), and diffusion magnetic resonance imaging (MRI) findings that most strongly supports a diagnosis of Todd paralysis (postictal transient paresis) rather than acute ischemic stroke. Base your reasoning on the following foundational principles: neuronal energy failure from arterial occlusion causes cytotoxic edema with reduced water mobility, which increases diffusion-weighted imaging (DWI) signal and decreases the apparent diffusion coefficient (ADC) in an arterial vascular territory, and this abnormality usually persists for several days; in contrast, seizures cause transient alterations in neuronal and glial activity and ion gradients that can produce brief, non-territorial cortical changes, often with EEG evidence of epileptiform activity or postictal focal slowing, and clinical deficits that resolve within approximately $24$ to $48$ hours.\n\nWhich option best differentiates Todd paralysis from acute ischemic stroke in a pediatric patient?\n\nA. Deficit improves substantially within $12$ hours; EEG shows focal slowing with intermittent epileptiform discharges over the contralateral perirolandic cortex; DWI is normal or shows a thin, non-territorial cortical ribbon hyperintensity without a corresponding ADC decrease.\n\nB. Deficit persists beyond $24$ hours; EEG is normal or shows diffuse slowing without epileptiform activity; DWI demonstrates a wedge-shaped lesion conforming to a single arterial territory with increased DWI signal and low ADC.\n\nC. Deficit fluctuates over several weeks; EEG remains normal; DWI remains normal at serial exams.\n\nD. Deficit resolves completely within $1$ hour; EEG shows generalized $3$ Hz spike-wave discharges; DWI shows bilateral thalamic diffusion restriction with low ADC.", "solution": "## Problem Validation\n\n### Step 1: Extract Givens\nThe problem statement provides the following information and foundational principles:\n- **Clinical Presentation**: A child presents with acute hemiparesis.\n- **Task**: Differentiate Todd paralysis (postictal transient paresis) from acute ischemic stroke.\n- **Principle 1 (Acute Ischemic Stroke)**:\n    - Pathophysiology: Neuronal energy failure from arterial occlusion causes cytotoxic edema.\n    - Effect on Water Mobility: Cytotoxic edema leads to reduced water mobility.\n    - Imaging Findings: Reduced water mobility results in increased diffusion-weighted imaging (DWI) signal and a decreased apparent diffusion coefficient (ADC).\n    - Lesion Characteristics: The abnormality is located in an arterial vascular territory.\n    - Temporal Course: The abnormality usually persists for several days.\n- **Principle 2 (Seizures / Todd Paralysis)**:\n    - Pathophysiology: Seizures cause transient alterations in neuronal and glial activity and ion gradients.\n    - Imaging Findings: Can produce brief, non-territorial cortical changes.\n    - EEG Findings: Often associated with EEG evidence of epileptiform activity or postictal focal slowing.\n    - Clinical Course: Clinical deficits (Todd paralysis) resolve within approximately $24$ to $48$ hours.\n\n### Step 2: Validate Using Extracted Givens\nThe problem statement is assessed against the required criteria:\n- **Scientifically Grounded**: The problem is firmly based on established principles of neurology, neuropathology, and neuroradiology. The descriptions of the pathophysiology and imaging characteristics of both acute ischemic stroke (cytotoxic edema, restricted diffusion in a vascular territory) and seizure-related changes (peri-ictal phenomena, transient deficits, EEG correlations) are factually correct and form the basis of modern clinical diagnosis.\n- **Well-Posed**: The problem is well-posed. It asks to identify a set of clinical, electrophysiological, and imaging findings that best distinguishes one diagnosis from another, based on a provided set of axioms. The task is clear, and a unique, logical solution can be derived from the given principles.\n- **Objective**: The problem is stated in precise, objective, and unbiased scientific language. It relies on foundational principles rather than subjective opinion.\n- **Completeness and Consistency**: The problem provides a self-contained and consistent set of principles sufficient to evaluate the options. There are no missing data or internal contradictions.\n- **Realism**: The clinical scenario and the described findings are realistic and commonly encountered in pediatric emergency medicine and neurology.\n\n### Step 3: Verdict and Action\nThe problem statement is valid as it is scientifically sound, well-posed, and objective. A solution can be derived by applying the provided principles.\n\n## Solution Derivation\n\nThe task is to identify the combination of findings that most strongly supports a diagnosis of Todd paralysis over acute ischemic stroke. We must use the foundational principles provided.\n\n- **For Todd Paralysis**: We expect a transient clinical deficit (resolving in approximately $24$ to $48$ hours), EEG evidence of a seizure (epileptiform discharges or postictal slowing), and MRI findings that are either normal or show transient, non-territorial changes, which notably lack the classic signature of true cytotoxic edema (i.e., may have high DWI signal but not a corresponding definite ADC decrease).\n- **For Acute Ischemic Stroke**: We expect a more persistent deficit, MRI evidence of cytotoxic edema (increased DWI signal *and* decreased ADC) in a defined arterial territory, and EEG findings that are less specific (e.g., focal slowing due to tissue injury, but not necessarily epileptiform activity).\n\nWe will now evaluate each option against these criteria.\n\n### Option-by-Option Analysis\n\n**A. Deficit improves substantially within $12$ hours; EEG shows focal slowing with intermittent epileptiform discharges over the contralateral perirolandic cortex; DWI is normal or shows a thin, non-territorial cortical ribbon hyperintensity without a corresponding ADC decrease.**\n\n- **Temporal Profile**: Improvement within $12$ hours is fully consistent with the expected resolution of Todd paralysis (within $24$ to $48$ hours).\n- **EEG**: The finding of focal slowing with epileptiform discharges over the contralateral perirolandic cortex (motor strip) is the classic electrophysiological signature of a focal seizure responsible for the hemiparesis.\n- **MRI**: The imaging description is crucial. A normal DWI, or a non-territorial cortical hyperintensity *without* a corresponding ADC decrease, precisely distinguishes a seizure-related phenomenon (like vasogenic edema or T2 shine-through) from the cytotoxic edema of an acute stroke. This pattern lacks the definitive marker of restricted diffusion.\n- **Conclusion**: This option perfectly aligns with the provided principles describing a seizure-related event (Todd paralysis) and directly contrasts with the expected findings of an acute ischemic stroke.\n- **Verdict**: **Correct**.\n\n**B. Deficit persists beyond $24$ hours; EEG is normal or shows diffuse slowing without epileptiform activity; DWI demonstrates a wedge-shaped lesion conforming to a single arterial territory with increased DWI signal and low ADC.**\n\n- **Temporal Profile**: Persistence of the deficit beyond $24$ hours argues against Todd paralysis and favors a more permanent injury like a stroke.\n- **EEG**: The absence of epileptiform activity makes a seizure less likely. Diffuse slowing is a non-specific finding.\n- **MRI**: A wedge-shaped, arterial territory lesion with increased DWI signal and low ADC is the textbook definition of an acute ischemic stroke, indicating irreversible cytotoxic edema.\n- **Conclusion**: Every element of this option points directly to a diagnosis of acute ischemic stroke, not Todd paralysis.\n- **Verdict**: **Incorrect**.\n\n**C. Deficit fluctuates over several weeks; EEG remains normal; DWI remains normal at serial exams.**\n\n- **Temporal Profile**: A deficit that fluctuates over weeks is not characteristic of Todd paralysis, which is a monophasic event resolving in hours to days. It is also not typical for a single acute stroke. This pattern suggests other pathologies (e.g., metabolic disorders, demyelination, or perhaps recurrent transient ischemic attacks).\n- **EEG**: A persistently normal EEG makes a seizure-related etiology highly unlikely.\n- **MRI**: A normal DWI rules out a significant ischemic stroke but does not, in combination with the other features, point to Todd paralysis.\n- **Conclusion**: This clinical picture is inconsistent with the typical presentation of either Todd paralysis or a single acute ischemic stroke.\n- **Verdict**: **Incorrect**.\n\n**D. Deficit resolves completely within $1$ hour; EEG shows generalized $3$ Hz spike-wave discharges; DWI shows bilateral thalamic diffusion restriction with low ADC.**\n\n- **Temporal Profile**: Rapid resolution within $1$ hour is consistent with a postictal state.\n- **EEG**: Generalized $3$ Hz spike-wave discharges are the hallmark of typical absence seizures. Absence seizures cause episodes of impaired awareness (staring spells), not focal motor deficits like hemiparesis. Therefore, the EEG finding is incongruent with the clinical sign of hemiparesis.\n- **MRI**: Bilateral thalamic diffusion restriction (high DWI, low ADC) indicates severe, often ischemic, injury to a specific deep brain structure (e.g., from an artery of Percheron occlusion). This is a definitive sign of stroke, not a transient postictal change.\n- **Conclusion**: This option contains fundamental inconsistencies. The EEG pattern does not match the clinical deficit, and the MRI findings indicate a severe, bilateral stroke, contradicting a diagnosis of benign Todd paralysis.\n- **Verdict**: **Incorrect**.", "answer": "$$\\boxed{A}$$", "id": "5192248"}, {"introduction": "Once an acute ischemic stroke is diagnosed, the immediate question is whether the patient is a candidate for intravenous thrombolysis, a high-risk, high-reward intervention. This practice requires you to construct a treatment protocol from the first principles of risk-benefit, balancing the potential to salvage brain tissue against the danger of hemorrhage. This exercise hones the critical skill of applying evidence-based criteria to an individual patient, a cornerstone of modern stroke care [@problem_id:5192290].", "problem": "A tertiary pediatric hospital seeks to draft an institutional protocol for Intravenous (IV) Tissue Plasminogen Activator (tPA) use in acute arterial ischemic stroke in children. The steering committee insists on justifying every inclusion and exclusion criterion from first principles of risk-benefit rather than from regulatory labeling. Consider the following clinical and pathophysiologic foundations, which you may treat as well-tested facts for the purpose of this derivation:\n\n- In arterial ischemic stroke, an intracranial arterial occlusion reduces regional cerebral blood flow below thresholds that define an irreversibly injured ischemic core and a surrounding potentially salvageable penumbra. Earlier reperfusion saves more penumbra and yields better functional outcomes.\n- The probability and magnitude of clinical benefit from IV thrombolysis increase when there is a confirmed target arterial occlusion and a small established infarct core, and they diminish as time from symptom onset increases.\n- The risk of symptomatic intracranial hemorrhage after thrombolysis increases with larger infarct core volume, with longer time from last-known-well, and with coagulopathy or recent surgery/trauma.\n- In children, the pretest probability of stroke among emergency presentations with focal deficits is lower than in adults due to a higher prevalence of stroke mimics; imaging that confirms or refutes large vessel occlusion can materially shift the posterior probability of true ischemic stroke.\n- Noncontrast Computed Tomography (CT) can exclude intracranial hemorrhage rapidly. Computed Tomography Angiography (CTA) or Magnetic Resonance Angiography (MRA) can confirm an arterial occlusion. The Alberta Stroke Program Early Computed Tomography Score (ASPECTS) provides a semiquantitative estimate of infarct core on early ischemia-sensitive CT; advanced perfusion imaging can estimate core and penumbra, but pediatric validation is limited compared with adults.\n- Adult data support IV tPA benefit up to $4.5$ hours from last-known-well when standard safety criteria are met; pediatric randomized data are limited, so a pediatric protocol should explicitly tie risk-benefit to physiologic indicators (confirmed occlusion, small core, short time) to minimize hemorrhagic harm and treatment of mimics.\n\nYou are asked to select the single best set of inclusion and exclusion criteria for a pediatric IV thrombolysis protocol that most closely follows the above first principles, explicitly incorporating imaging-confirmed occlusion and time since onset.\n\nWhich option is most appropriate?\n\nA. Inclusion: age $2$–$17$ years; a disabling, measurable focal neurological deficit consistent with anterior or posterior circulation ischemia; last-known-well $\\leq 4.5$ hours; noncontrast CT excluding intracranial hemorrhage; CTA or MRA demonstrating a corresponding intracranial arterial occlusion; no large established infarct core on baseline imaging, for example, CT ASPECTS $\\geq 6$ if anterior circulation. Exclusion: platelet count  $100 \\times 10^9/\\text{L}$, International Normalized Ratio (INR) > $1.7$ or use of direct oral anticoagulant within the past $48$ hours, glucose  $50$ mg/dL or > $400$ mg/dL until corrected, uncontrolled blood pressure with Systolic Blood Pressure (SBP) > $185$ mm Hg or Diastolic Blood Pressure (DBP) > $110$ mm Hg despite treatment, intracranial hemorrhage, known high-risk intracranial structural lesion with bleeding propensity, major surgery or significant head trauma within $14$ days, rapidly improving or non-disabling symptoms.\n\nB. Inclusion: age $2$–$17$ years; focal neurological deficit; last-known-well $\\leq 9$ hours if any perfusion mismatch is present on CT or Magnetic Resonance Imaging (MRI) perfusion maps; noncontrast CT excluding hemorrhage. Exclusion: none beyond intracranial hemorrhage and known allergy to tPA. Confirmation of arterial occlusion is not required if perfusion maps show mismatch.\n\nC. Inclusion: age $2$–$17$ years; any focal neurological deficit suggestive of stroke; last-known-well $\\leq 4.5$ hours; noncontrast CT excluding hemorrhage. Exclusion: none related to laboratory abnormalities, recent surgery, or blood pressure, because these adult-derived exclusions are not proven in children; arterial occlusion imaging is optional to avoid delaying treatment.\n\nD. Inclusion: age $\\geq 16$ years only; measurable neurological deficit; last-known-well $\\leq 4.5$ hours; noncontrast CT excluding hemorrhage. Exclusion: none other than intracranial hemorrhage. Vascular imaging and core estimation should not delay therapy because they are not required in adult protocols.\n\nChoose the single best option.", "solution": "### Step 1: Extract Givens\n\nThe problem statement provides the following \"well-tested facts\" to be used as first principles for deriving a pediatric IV tPA protocol:\n1.  **Pathophysiology**: Arterial ischemic stroke involves an occluded artery, an ischemic core (irreversibly injured), and a penumbra (salvageable tissue). Earlier reperfusion saves more penumbra and improves outcomes.\n2.  **Benefit Factors**: The benefit from IV thrombolysis increases with a confirmed target arterial occlusion and a small established infarct core. Benefit diminishes as time from onset increases.\n3.  **Risk Factors**: Risk of symptomatic intracranial hemorrhage (sICH) increases with larger infarct core volume, longer time from last-known-well (LKW), coagulopathy, and recent surgery/trauma.\n4.  **Pediatric Context**: The pretest probability of stroke in children presenting with focal deficits is lower than in adults due to a higher prevalence of stroke mimics. Imaging confirmation of a large vessel occlusion (LVO) is crucial to increase the post-test probability of true ischemic stroke.\n5.  **Imaging Modalities**:\n    *   Noncontrast Computed Tomography (NCCT) rapidly excludes intracranial hemorrhage (ICH).\n    *   Computed Tomography Angiography (CTA) or Magnetic Resonance Angiography (MRA) can confirm an arterial occlusion.\n    *   The Alberta Stroke Program Early Computed Tomography Score (ASPECTS) provides a semiquantitative estimate of infarct core size.\n    *   Advanced perfusion imaging can estimate core and penumbra, but its pediatric validation is limited compared to adults.\n6.  **Guiding Principle**: Adult data support IV tPA benefit up to $4.5$ hours from LKW with standard safety criteria. A pediatric protocol should explicitly tie risk-benefit to physiologic indicators: confirmed occlusion, small core, and short time window, to minimize harm from hemorrhage and from treating mimics.\n\nThe task is to identify the set of criteria that most closely adheres to these principles.\n\n### Step 2: Validate Using Extracted Givens\n\nThe problem statement provides a set of axioms (the \"well-tested facts\") and asks for a logical deduction based on them. This constitutes a well-posed problem in medical reasoning and logic.\n\n-   **Scientifically Grounded**: The provided facts are consistent with established principles of stroke neurology and pathophysiology, including the concepts of the ischemic penumbra, time-dependent benefits of reperfusion, and known risk factors for thrombolysis-associated hemorrhage.\n-   **Well-Posed**: The question asks to select the \"single best set\" of criteria from a list of options, based on a closed set of given principles. This structure allows for a unique solution derived by systematically comparing each option against the provided principles.\n-   **Objective**: The problem is stated in objective, clinical language. The \"facts\" are presented as axioms for the purpose of the problem, removing subjectivity.\n-   **Completeness**: The axioms are sufficient to construct a framework for a logically sound protocol and to critically evaluate the given options.\n-   **No Flaws**: The problem does not violate any of the specified invalidity criteria. It is a rigorous exercise in applying first principles to a clinical scenario.\n\n### Step 3: Verdict and Action\n\nThe problem statement is valid. I will proceed with the solution and evaluation of the options.\n\n### Solution Derivation\n\nThe guiding principles for an ideal pediatric protocol, derived directly from the provided facts, are as follows:\n\n1.  **Patient Population**: The protocol is for a \"tertiary pediatric hospital,\" so it should apply to the pediatric age range (e.g., up to $17$ or $18$ years). Clinical presentation should be significant enough to warrant the risks of therapy, i.e., a \"disabling\" deficit.\n2.  **Time Window**: Benefit diminishes and risk increases with time (Facts 2, 3). Adult data support a time window up to $4.5$ hours (Fact 6). Given the limited pediatric data and the emphasis on safety, a conservative window of $\\leq 4.5$ hours from last-known-well is the most logical choice.\n3.  **Core Imaging Requirements**: The protocol must be \"explicitly\" tied to physiologic indicators (Fact 6).\n    *   **Exclude Hemorrhage**: NCCT must be used to rule out ICH (Fact 5). This is a non-negotiable safety step.\n    *   **Confirm Occlusion**: To maximize benefit (Fact 2) and minimize treatment of mimics (Fact 4), the protocol must require confirmation of a corresponding arterial occlusion via CTA or MRA. This is a critical requirement given the pediatric context.\n    *   **Estimate Core Size**: To maximize benefit (Fact 2) and minimize hemorrhage risk (Fact 3), the protocol must ensure the infarct core is small. Using a tool like ASPECTS is a direct application of this principle (Fact 5).\n4.  **Core Exclusion Criteria**: The protocol must mitigate the risk of sICH.\n    *   **Large Infarct Core**: Must be an exclusion, as it increases hemorrhage risk (Fact 3).\n    *   **Coagulopathy**: Must be an exclusion, as it increases hemorrhage risk (Fact 3).\n    *   **Recent Surgery/Trauma**: Must be an exclusion, as it increases hemorrhage risk (Fact 3).\n    *   Other standard safety exclusions mentioned in adult guidelines (e.g., uncontrolled hypertension, severe hypoglycemia/hyperglycemia) are logical extensions of the risk-benefit principle, as they increase procedural risk or are associated with stroke mimics.\n\nNow, I will evaluate each option against this derived ideal protocol.\n\n### Option-by-Option Analysis\n\n**Option A**\n\n*   **Inclusion Criteria**:\n    *   `age 2–17 years`: Appropriate for a pediatric protocol.\n    *   `disabling, measurable focal neurological deficit`: Correctly balances risk and benefit.\n    *   `last-known-well ≤ 4.5 hours`: Adheres to the time window supported by data and first principles (Facts 2, 3, 6).\n    *   `noncontrast CT excluding intracranial hemorrhage`: Correctly incorporates the essential initial safety check (Fact 5).\n    *   `CTA or MRA demonstrating a corresponding intracranial arterial occlusion`: Precisely follows the key directive to confirm an occlusion to maximize benefit and minimize treating mimics (Facts 2, 4, 6).\n    *   `no large established infarct core... CT ASPECTS ≥ 6`: Directly applies the principle of selecting for a small core to enhance benefit and reduce risk (Facts 2, 3, 6).\n*   **Exclusion Criteria**:\n    *   Lists of exclusions for coagulopathy (`platelet count  $100 \\times 10^9/\\text{L}$`, `INR > $1.7$`, anticoagulant use), metabolic derangement (glucose), uncontrolled blood pressure, prior trauma/surgery, and rapidly improving symptoms are all directly supported by the first principle of minimizing hemorrhage risk (Fact 3) and ensuring benefit outweighs risk.\n*   **Verdict**: **Correct**. This option meticulously integrates every principle provided in the problem statement into a coherent, safe, and logically sound protocol. It explicitly requires confirmation of occlusion and estimation of a small core, respects the conservative time window, and includes appropriate safety exclusions based on the risk-benefit principles.\n\n**Option B**\n\n*   **Inclusion Criteria**:\n    *   `last-known-well ≤ 9 hours`: This is an extended time window. The problem statement notes limited pediatric validation for advanced imaging (Fact 5) and supports a window based on adult data (up to $4.5$ hours, Fact 6). A $9$-hour window represents an aggressive deviation not justified by the provided principles.\n    *   `Confirmation of arterial occlusion is not required if perfusion maps show mismatch`: This directly contradicts the explicit instruction that a pediatric protocol should be tied to a \"confirmed occlusion\" (Fact 6) and ignores the importance of this confirmation for ruling out mimics in children (Fact 4).\n*   **Exclusion Criteria**:\n    *   `none beyond intracranial hemorrhage and known allergy to tPA`: This is dangerously incomplete. It ignores the explicit risk factors of coagulopathy and recent surgery/trauma mentioned in Fact 3.\n*   **Verdict**: **Incorrect**. This option proposes a protocol that is substantially more aggressive and less safe than what is justifiable by the provided first principles. It omits critical requirements for confirming occlusion and screening for major hemorrhage risk factors.\n\n**Option C**\n\n*   **Inclusion Criteria**:\n    *   `arterial occlusion imaging is optional`: This is a critical flaw. It violates the core instruction to use imaging to confirm an occlusion, especially in the pediatric population where mimics are common (Facts 4, 6).\n*   **Exclusion Criteria**:\n    *   `none related to laboratory abnormalities, recent surgery, or blood pressure, because these adult-derived exclusions are not proven in children`: This reflects a grave misinterpretation of the task. The task is to reason from \"first principles of risk-benefit,\" not to discard principles simply because they are also used in adults. Fact 3 explicitly states coagulopathy and recent surgery/trauma increase hemorrhage risk. This is a pathophysiologic principle, independent of age. Ignoring these risks is a direct violation of the directive.\n*   **Verdict**: **Incorrect**. This option creates an unsafe protocol by making a key diagnostic step optional and by incorrectly discarding fundamental safety exclusions related to hemorrhage risk.\n\n**Option D**\n\n*   **Inclusion Criteria**:\n    *   `age ≥ 16 years only`: This is inconsistent with the setting of a \"tertiary pediatric hospital\" and excludes the vast majority of children. A pediatric protocol should cover the pediatric age range.\n    *   `Vascular imaging and core estimation should not delay therapy because they are not required in adult protocols`: This logic is flawed. The problem explicitly states that a *pediatric* protocol should differ from adult ones by being more strictly tied to physiologic indicators like confirmed occlusion and small core size due to the higher rate of mimics and limited data (Facts 4, 6).\n*   **Exclusion Criteria**:\n    *   `none other than intracranial hemorrhage`: Like options B and C, this dangerously ignores the key risk factors for hemorrhage outlined in Fact 3.\n*   **Verdict**: **Incorrect**. This option fails by inappropriately restricting the patient population and by rejecting the very principles (imaging-confirmed occlusion and core assessment) that the problem statement identifies as crucial for a safe pediatric protocol.", "answer": "$$\\boxed{A}$$", "id": "5192290"}, {"introduction": "After a patient has been deemed an appropriate candidate for thrombolytic therapy, precision in medication administration is paramount to ensure efficacy and safety. This problem provides hands-on practice with the multi-step calculation required for alteplase, from the total weight-based dose to the specific bolus and infusion parameters. Successfully completing this calculation demonstrates a foundational skill for any clinician involved in the acute management of pediatric stroke [@problem_id:5192239].", "problem": "A $10$-year-old child with confirmed acute arterial ischemic stroke is deemed eligible for intravenous recombinant tissue plasminogen activator (tissue plasminogen activator, tPA) therapy with alteplase under a pediatric stroke protocol. The child weighs $35$ kg. The protocol specifies a total mass-normalized dose of $0.9$ mg/kg, administered as an initial $10\\%$ intravenous bolus followed by a continuous infusion of the remaining $90\\%$ over $60$ minutes. Clinicians sometimes apply an adult maximum total dose cap of $90$ mg; assume this cap applies if the calculated weight-based total would exceed it.\n\nStarting only from the following fundamental bases: (i) the definition of weight-based dosing as total dose equals mass-normalized dose multiplied by body mass, (ii) the definition of a proportion as a fraction of a whole, and (iii) the definition of infusion rate as dose delivered per unit time, derive the absolute total dose, the absolute bolus dose, the absolute infusion dose, and the infusion rate.\n\nState any cap check clearly and apply it if limiting. Round your results to three significant figures. Express doses in mg and the rate in mg/min. Present your final answer as a single row matrix in the order: total dose (mg), bolus dose (mg), infusion dose (mg), infusion rate (mg/min). Do not include units inside the final boxed answer.", "solution": "The problem is evaluated for validity before proceeding to a solution.\n\n### Step 1: Extract Givens\n- Child's body mass, $m = 35$ kg.\n- Total mass-normalized dose of alteplase, $d_{norm} = 0.9$ mg/kg.\n- Proportion of total dose for initial intravenous bolus, $P_{bolus} = 10\\%$.\n- Proportion of total dose for continuous infusion, $P_{infusion} = 90\\%$.\n- Duration of continuous infusion, $T_{infusion} = 60$ minutes.\n- Adult maximum total dose cap, $D_{max} = 90$ mg.\n- Assumption: The cap applies if the calculated weight-based total dose exceeds it.\n- Fundamental bases for derivation:\n    - (i) Definition of weight-based dosing: total dose equals mass-normalized dose multiplied by body mass.\n    - (ii) Definition of a proportion as a fraction of a whole.\n    - (iii) Definition of infusion rate as dose delivered per unit time.\n- Output requirements:\n    - Derive: absolute total dose, absolute bolus dose, absolute infusion dose, and the infusion rate.\n    - Round final results to three significant figures.\n    - Express doses in mg and the rate in mg/min.\n    - Present the final answer as a single row matrix.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded. The specified dose of alteplase ($0.9$ mg/kg), administration protocol ($10\\%$ bolus, $90\\%$ infusion over $60$ minutes), and maximum dose cap ($90$ mg) are consistent with established clinical guidelines for thrombolytic therapy in acute ischemic stroke (e.g., American Heart Association/American Stroke Association guidelines). The provided values for the child's weight and the dosage are physically and medically realistic. The problem is well-posed, objective, and self-contained, with all necessary information provided for a unique solution. It does not violate any of the invalidity criteria.\n\n### Step 3: Verdict and Action\nThe problem is valid. A formal solution will be derived.\n\n### Derivation\nLet $m$ be the body mass of the child, $d_{norm}$ be the mass-normalized dose, and $D_{max}$ be the maximum total dose cap.\nThe given values are:\n- $m = 35$ kg\n- $d_{norm} = 0.9$ mg/kg\n- $D_{max} = 90$ mg\n\n**1. Calculate the initial weight-based total dose ($D_{calc}$)**\nBased on the provided definition (i), the total dose is the product of the mass-normalized dose and the body mass.\n$$D_{calc} = d_{norm} \\times m$$\nSubstituting the given values:\n$$D_{calc} = (0.9 \\text{ mg/kg}) \\times (35 \\text{ kg}) = 31.5 \\text{ mg}$$\n\n**2. Apply the maximum dose cap**\nThe problem requires checking if the calculated dose $D_{calc}$ exceeds the maximum cap $D_{max}$.\nThe condition to check is $D_{calc}  D_{max}$.\n$$31.5 \\text{ mg}  90 \\text{ mg}$$\nThis statement is false. Therefore, the dose cap does not apply, and the actual total dose to be administered, $D_{total}$, is equal to the calculated dose.\n$$D_{total} = D_{calc} = 31.5 \\text{ mg}$$\n\n**3. Calculate the absolute bolus dose ($D_{bolus}$)**\nThe bolus dose is a proportion, $P_{bolus} = 10\\% = 0.10$, of the total dose. Based on the provided definition (ii):\n$$D_{bolus} = P_{bolus} \\times D_{total}$$\n$$D_{bolus} = 0.10 \\times 31.5 \\text{ mg} = 3.15 \\text{ mg}$$\n\n**4. Calculate the absolute infusion dose ($D_{infusion}$)**\nThe infusion dose is the remaining proportion, $P_{infusion} = 90\\% = 0.90$, of the total dose.\n$$D_{infusion} = P_{infusion} \\times D_{total}$$\n$$D_{infusion} = 0.90 \\times 31.5 \\text{ mg} = 28.35 \\text{ mg}$$\nA consistency check confirms that the sum of the bolus and infusion doses equals the total dose: $D_{bolus} + D_{infusion} = 3.15 \\text{ mg} + 28.35 \\text{ mg} = 31.5 \\text{ mg} = D_{total}$.\n\n**5. Calculate the infusion rate ($R_{infusion}$)**\nThe infusion is administered over a duration $T_{infusion} = 60$ min. Based on the provided definition (iii), the infusion rate is the dose delivered per unit time.\n$$R_{infusion} = \\frac{D_{infusion}}{T_{infusion}}$$\n$$R_{infusion} = \\frac{28.35 \\text{ mg}}{60 \\text{ min}} = 0.4725 \\text{ mg/min}$$\n\n**6. Rounding to Three Significant Figures**\nThe problem requires that the final results be rounded to three significant figures.\n- Total Dose: $D_{total} = 31.5$ mg. This value already has three significant figures.\n- Bolus Dose: $D_{bolus} = 3.15$ mg. This value already has three significant figures.\n- Infusion Dose: $D_{infusion} = 28.35$ mg. Rounding to three significant figures gives $28.4$ mg.\n- Infusion Rate: $R_{infusion} = 0.4725$ mg/min. Rounding to three significant figures gives $0.473$ mg/min.\n\nThe required values, expressed in the correct units and rounded to three significant figures, are:\n- Total Dose: $31.5$ mg\n- Bolus Dose: $3.15$ mg\n- Infusion Dose: $28.4$ mg\n- Infusion Rate: $0.473$ mg/min\n\nThese results are to be presented in a single row matrix in the specified order.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n31.5  3.15  28.4  0.473\n\\end{pmatrix}\n}\n$$", "id": "5192239"}]}